These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 10194718)

  • 1. Quantitative analysis of cerebral microvascular hemodynamics with T2-weighted dynamic MR imaging.
    Koshimoto Y; Yamada H; Kimura H; Maeda M; Tsuchida C; Kawamura Y; Ishii Y
    J Magn Reson Imaging; 1999 Mar; 9(3):462-7. PubMed ID: 10194718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging.
    Rempp KA; Brix G; Wenz F; Becker CR; Gückel F; Lorenz WJ
    Radiology; 1994 Dec; 193(3):637-41. PubMed ID: 7972800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral hemodynamics in asymptomatic patients with internal carotid artery occlusion: a dynamic susceptibility contrast MR and transcranial Doppler study.
    Apruzzese A; Silvestrini M; Floris R; Vernieri F; Bozzao A; Hagberg G; Caltagirone C; Masala S; Simonetti G
    AJNR Am J Neuroradiol; 2001; 22(6):1062-7. PubMed ID: 11415898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging.
    Hakyemez B; Erdogan C; Ercan I; Ergin N; Uysal S; Atahan S
    Clin Radiol; 2005 Apr; 60(4):493-502. PubMed ID: 15767107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assesment of perfusion in glial tumors with arterial spin labeling; comparison with dynamic susceptibility contrast method.
    Cebeci H; Aydin O; Ozturk-Isik E; Gumus C; Inecikli F; Bekar A; Kocaeli H; Hakyemez B
    Eur J Radiol; 2014 Oct; 83(10):1914-9. PubMed ID: 25087109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of contrast agents with high molarity and with weak protein binding in cerebral perfusion imaging at 3 T.
    Thilmann O; Larsson EM; Björkman-Burtscher IM; Ståhlberg F; Wirestam R
    J Magn Reson Imaging; 2005 Nov; 22(5):597-604. PubMed ID: 16200539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation-induced regional cerebral blood volume (rCBV) changes in normal brain and low-grade astrocytomas: quantification and time and dose-dependent occurrence.
    Fuss M; Wenz F; Scholdei R; Essig M; Debus J; Knopp MV; Wannenmacher M
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):53-8. PubMed ID: 10924971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Half-fourier acquisition single-shot turbo spin-echo (HASTE) MR: comparison with fast spin-echo MR in diseases of the brain.
    Patel MR; Klufas RA; Alberico RA; Edelman RR
    AJNR Am J Neuroradiol; 1997 Oct; 18(9):1635-40. PubMed ID: 9367310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of HASTE and segmented-HASTE sequences with a T2-weighted fast spin-echo sequence in the screening evaluation of the brain.
    Sugahara T; Korogi Y; Hirai T; Hamatake S; Ikushima I; Shigematu Y; Takahashi M
    AJR Am J Roentgenol; 1997 Nov; 169(5):1401-10. PubMed ID: 9353469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of dynamic susceptibility-contrast MRI (DSC-MRI) to assess perfusion changes in the ipsilateral brain parenchyma from glioblastoma.
    Ulmer S; Liess C; Kesari S; Otto N; Straube T; Jansen O
    J Neurooncol; 2009 Jan; 91(2):213-20. PubMed ID: 18807224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of cerebral hemodynamics with perfusion-weighted MR imaging: comparison with pre- and post-acetazolamide 133Xe-SPECT in occlusive carotid disease.
    Kikuchi K; Murase K; Miki H; Kikuchi T; Sugawara Y; Mochizuki T; Ikezoe J; Ohue S
    AJNR Am J Neuroradiol; 2001 Feb; 22(2):248-54. PubMed ID: 11156764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas.
    Thomsen H; Steffensen E; Larsson EM
    Acta Radiol; 2012 Feb; 53(1):95-101. PubMed ID: 22114021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of scopolamine challenge on regional cerebral blood volume. A pharmacological model to validate the use of contrast enhanced magnetic resonance imaging to assess cerebral blood volume in a canine model of aging.
    Tapp PD; Chu Y; Araujo JA; Chiou JY; Head E; Milgram NW; Su MY
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Mar; 29(3):399-406. PubMed ID: 15795048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification of hemodynamics from dynamic-susceptibility-contrast magnetic resonance (DSC-MR) brain images using noiseless independent factor analysis.
    Chou YC; Teng MM; Guo WY; Hsieh JC; Wu YT
    Med Image Anal; 2007 Jun; 11(3):242-53. PubMed ID: 17433760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole brain quantitative CBF, CBV, and MTT measurements using MRI bolus tracking: implementation and application to data acquired from hyperacute stroke patients.
    Smith AM; Grandin CB; Duprez T; Mataigne F; Cosnard G
    J Magn Reson Imaging; 2000 Sep; 12(3):400-10. PubMed ID: 10992307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of regional cerebral blood volume in acute human stroke by use of single-slice dynamic susceptibility contrast-enhanced magnetic resonance imaging.
    Röther J; Gückel F; Neff W; Schwartz A; Hennerici M
    Stroke; 1996 Jun; 27(6):1088-93. PubMed ID: 8650719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose.
    Manka C; Träber F; Gieseke J; Schild HH; Kuhl CK
    Radiology; 2005 Mar; 234(3):869-77. PubMed ID: 15665227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age dependency of the regional cerebral blood volume (rCBV) measured with dynamic susceptibility contrast MR imaging (DSC).
    Wenz F; Rempp K; Brix G; Knopp MV; Gückel F; Hess T; van Kaick G
    Magn Reson Imaging; 1996; 14(2):157-62. PubMed ID: 8847971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of echo time variation on perfusion assessment using dynamic susceptibility contrast MR imaging at 3 tesla.
    Thilmann O; Larsson EM; Björkman-Burtscher IM; Ståhlberg F; Wirestam R
    Magn Reson Imaging; 2004 Sep; 22(7):929-35. PubMed ID: 15288133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of regional tracer delay on CBF in healthy subjects measured with dynamic susceptibility contrast-enhanced MRI: comparison with 15O-PET.
    Ibaraki M; Shimosegawa E; Toyoshima H; Ishigame K; Ito H; Takahashi K; Miura S; Kanno I
    Magn Reson Med Sci; 2005; 4(1):27-34. PubMed ID: 16127251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.